The article you requested is

Weight Gain and Antipsychotics

J Clin Psychiatry 2005;66(7):950-951 [letter]

Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: The recent (November 2004) Commentary by Kane et al.1 provides readers with a comprehensive overview of the current situation with regard to the controversy surrounding the association of adverse metabolic effects with atypical antipsychotic drugs. The discussion reported in the Commentary was a response to a recently published consensus statement,2 as well as the U.S. Food and Drug Administration’s suggested changes to labeling, and was intended to advise clinicians how these recommendations may affect their clinical practice. The panel of experts correctly identify the important areas of uncertainty related to this topic, and they highlight the need for further rigorous studies designed to examine the differential effects of individual atypical agents.​